Hindustan Foods reported a consolidated net profit of ₹42.76 crore for the quarter ended June 30, 2026, representing a 32.76% year-on-year increase from ₹32.21 crore in Q1FY25. The growth was driven by an 18% surge in revenue from operations to ₹1,201.08 crore, reflecting expanded contract manufacturing activities and recent acquisitions. Standalone net profit also climbed 32.24% to ₹40.81 crore.

The Board of Directors approved the unaudited financial results at a meeting held on August 4, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by MSKA & Associates LLP, the statutory auditors, who issued an unmodified conclusion. The filing was made pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

Consolidated revenue from operations rose to ₹1,201.08 crore in Q1FY26, up from ₹1,018.69 crore in the corresponding period of FY25. Other income increased to ₹5.91 crore from ₹3.47 crore. Total expenses stood at ₹1,150.32 crore, compared to ₹979.46 crore previously. Cost of materials consumed accounted for the largest expense head at ₹964.32 crore.

Standalone revenue from operations grew 23.42% to ₹934.57 crore. Standalone net profit reached ₹40.81 crore, up from ₹30.86 crore in Q1FY25. Basic earnings per share stood at ₹3.37 on a standalone basis and ₹3.53 on a consolidated basis.

Strategic Acquisitions and Restatements

On April 1, 2026, Hindustan Foods completed the acquisition of the manufacturing facility of Ultra Beauty Care Private Limited in Aurangabad, Maharashtra, for ₹21.81 crore. The company recorded net assets acquired at ₹24.19 crore and a capital reserve of ₹2.38 crore on a provisional basis. The inclusion of this facility from April 1 to June 30, 2026, makes current quarter figures incomparable with prior periods.

Additionally, previous quarter results were restated to reflect the Scheme of Arrangement involving the business combination with Nashik Manufacturing Unit of Avalon Cosmetics Private Limited and the amalgamation of Vanity Case India Private Limited. Both schemes became operative on March 31, 2026, following approval by the National Company Law Tribunal (Mumbai Bench).

What the Numbers Show

The disproportionate growth in standalone revenue (23.42%) compared to consolidated revenue (17.93%) suggests that the parent entity’s core operations expanded faster than the group average, potentially offsetting lower-margin contributions from subsidiaries or associates. Furthermore, the share of loss from associate Asar Green Kabadi Private Limited remained minimal at ₹0.09 crore, indicating limited drag on overall profitability despite the entity being unprofitable.

Hindustan Foods delivered a record quarterly performance in Q1FY27, reporting a consolidated net profit of ₹42.8 crore, a 33% year-on-year increase from ₹32.2 crore in the same period last year. The earnings surge was driven by an 18% rise in total income to ₹1,207.0 crore and a 26% jump in EBITDA to ₹106.3 crore, reflecting strong operational leverage despite headwinds in its footwear segment. Reinforcing its growth trajectory, the Board authorized additional investments of ₹190 crore for new expansion projects, bringing the total capital expenditure plan for FY27 to ₹340 crore.

The financial results were approved by the Board of Directors on August 4, 2026, and disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. MSKA & Associates LLP, the statutory auditors, issued an unmodified conclusion on the unaudited financial statements after reviewing them in accordance with Standard on Review Engagements (SRE) 2410. The results have been prepared in compliance with Indian Accounting Standard 34 (Ind AS 34) on Interim Financial Reporting.

Financial Performance Highlights

Hindustan Foods demonstrated resilience across multiple business verticals, with profitability outpacing top-line growth. Profit before tax (PBT) before exceptional items rose 33% to ₹56.6 crore from ₹42.7 crore in Q1FY26. The company attributed this performance to healthy operating leverage in key businesses and strategic steps taken to mitigate the effects of GST inversion. However, the footwear business faced temporary cost pressures due to higher raw material prices linked to geopolitical tensions in the Middle East and exceptional wage revisions in Haryana under the new Labour Code. Management noted that alternative raw material sources have been secured, and discussions are underway with customers to pass through these costs.

Operational execution remained strong, with record production volumes in the ice cream and beverages business during the summer season. In July, the Silvassa manufacturing facility, which produces Home & Personal Care products, faced disruptions due to record rains. Production has partially resumed, with full operations targeted by the end of August. The facility is adequately insured, and management does not expect any material impact on long-term operations.

Strategic Investments and Segment Updates

The Board’s decision to increase capital expenditure underscores its commitment to expanding manufacturing capabilities. The additional ₹190 crore investment, added to the previously announced ₹150 crore carried forward from FY26, brings the total FY27 capex to ₹340 crore. These investments are allocated across key geographies and product categories:

• Food & Beverages: ₹210 crore at facilities in Coimbatore, Mysuru, Goa, Aurangabad, and Hyderabad. This includes a brownfield Greek Yogurt facility in Goa (₹60 crore) targeting commercial production in Q3FY27, marking entry into the yogurt segment.
• Ice Cream: ₹80 crore at Panipat for Phase 2 expansion, following the successful commissioning of the state-of-the-art facility in Q1FY27.
• Home & Personal Care: ₹50 crore at Lucknow for a greenfield detergent bars and liquid facility, targeted to become fully operational by Q4FY27.

Sameer R. Kothari, Managing Director, stated that these investments reinforce confidence in the long-term growth opportunity. Mayank Samdani, Group CFO, reaffirmed the FY27 PAT guidance of ₹200–220 crore, noting that while certain businesses will transition their revenue recognition methodology in Q2 and Q3 FY27—potentially moderating reported revenues—absolute profitability will remain unaffected.

What the Numbers Show

A critical observation is the divergence between revenue growth and profitability expansion. While total income grew by 18%, EBITDA and PAT both surged by 26% and 33%, respectively. This indicates significant operating leverage, likely driven by the ramp-up of recently commissioned capacities and improved asset utilization. The company’s capital deployment strategy remains disciplined, with projects evaluated against an ~18% ROCE threshold. Investors should monitor the footwear segment closely, as raw material cost pressures and wage revisions could impact near-term margins if cost pass-through mechanisms face delays. The substantial increase in capex to ₹340 crore suggests that future growth will be capital-intensive, requiring sustained high utilization rates to justify the return on invested capital.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE254N01026/93417ada-958e-40ce-888b-0ea8c42de864.pdf